Peter Järver

1.5k total citations
18 papers, 934 citations indexed

About

Peter Järver is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Peter Järver has authored 18 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Genetics and 4 papers in Immunology. Recurrent topics in Peter Järver's work include RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (11 papers) and Virus-based gene therapy research (7 papers). Peter Järver is often cited by papers focused on RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (11 papers) and Virus-based gene therapy research (7 papers). Peter Järver collaborates with scholars based in Sweden, United Kingdom and Estonia. Peter Järver's co-authors include Ülo Langel, Samir EL Andaloussi, Henrik J. Johansson, Michael J. Gait, Imre Mäger, Liz O’Donovan, Matthew J. A. Wood, Thibault Coursindel, Caroline Godfrey and Kent Langel and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Scientific Reports.

In The Last Decade

Peter Järver

18 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Järver Sweden 14 832 186 119 105 72 18 934
Julien Depollier France 5 918 1.1× 206 1.1× 125 1.1× 135 1.3× 95 1.3× 5 1.1k
Akiko Tadokoro Japan 7 709 0.9× 150 0.8× 123 1.0× 90 0.9× 75 1.0× 7 781
J Seery United Kingdom 5 862 1.0× 284 1.5× 78 0.7× 185 1.8× 76 1.1× 8 1.1k
Bryan R. Meade United States 10 1.1k 1.3× 237 1.3× 62 0.5× 96 0.9× 98 1.4× 11 1.1k
Caroline Palm‐Apergi Sweden 11 750 0.9× 84 0.5× 185 1.6× 66 0.6× 73 1.0× 19 852
C. Jeffrey United States 7 416 0.5× 143 0.8× 119 1.0× 120 1.1× 37 0.5× 8 576
Saïd Abes France 16 1.1k 1.3× 267 1.4× 70 0.6× 52 0.5× 49 0.7× 18 1.2k
Peter A. Leland United States 11 682 0.8× 142 0.8× 31 0.3× 83 0.8× 24 0.3× 16 820
Peter Guterstam Sweden 10 917 1.1× 167 0.9× 132 1.1× 80 0.8× 71 1.0× 14 946
Laurence Crombez France 12 856 1.0× 187 1.0× 103 0.9× 85 0.8× 146 2.0× 13 931

Countries citing papers authored by Peter Järver

Since Specialization
Citations

This map shows the geographic impact of Peter Järver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Järver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Järver more than expected).

Fields of papers citing papers by Peter Järver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Järver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Järver. The network helps show where Peter Järver may publish in the future.

Co-authorship network of co-authors of Peter Järver

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Järver. A scholar is included among the top collaborators of Peter Järver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Järver. Peter Järver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Järver, Peter, et al.. (2021). A Population Genomic Investigation of Immune Cell Diversity and Phagocytic Capacity in a Butterfly. Genes. 12(2). 279–279. 5 indexed citations
2.
Poux, Candice, Joseph Bergenstråhle, Vanessa Contreras, et al.. (2019). A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection. Frontiers in Immunology. 10. 2161–2161. 21 indexed citations
3.
Järver, Peter, Candice Poux, AnnSofi Sandberg, et al.. (2018). Single-Stranded Nucleic Acids Regulate TLR3/4/7 Activation through Interference with Clathrin-Mediated Endocytosis. Scientific Reports. 8(1). 15841–15841. 14 indexed citations
4.
Järver, Peter, Eman M. Zaghloul, Andrey Arzumanov, et al.. (2015). Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides. Nucleic Acid Therapeutics. 25(2). 65–77. 17 indexed citations
5.
Shabanpoor, Fazel, Graham McClorey, Amer F. Saleh, et al.. (2014). Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy. Nucleic Acids Research. 43(1). 29–39. 26 indexed citations
6.
Järver, Peter, Liz O’Donovan, & Michael J. Gait. (2013). A Chemical View of Oligonucleotides for Exon Skipping and Related Drug Applications. Nucleic Acid Therapeutics. 24(1). 37–47. 69 indexed citations
7.
Yu, Feifan, Peter Järver, & Per‐Åke Nygren. (2013). Tailor-Making a Protein A-Derived Domain for Efficient Site-Specific Photocoupling to Fc of Mouse IgG1. PLoS ONE. 8(2). e56597–e56597. 28 indexed citations
8.
Honarvar, Hadis, Karl Andersson, Jennie Malmberg, et al.. (2013). Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for In Vivo molecular imaging. Nuclear Medicine and Biology. 40(3). 378–386. 16 indexed citations
9.
Järver, Peter, Thibault Coursindel, Samir EL Andaloussi, et al.. (2012). Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA. Molecular Therapy — Nucleic Acids. 1. e27–e27. 86 indexed citations
10.
Coursindel, Thibault, Peter Järver, & Michael J. Gait. (2012). Peptide-Based In Vivo Delivery Agents for Oligonucleotides and siRNA. Nucleic Acid Therapeutics. 22(2). 71–76. 8 indexed citations
11.
Järver, Peter, et al.. (2011). Chemical synthesis and evaluation of a backbone‐cyclized minimized 2‐helix Z‐domain. Journal of Peptide Science. 17(6). 463–469. 7 indexed citations
12.
Järver, Peter, Imre Mäger, & Ülo Langel. (2010). In vivo biodistribution and efficacy of peptide mediated delivery. Trends in Pharmacological Sciences. 31(11). 528–535. 121 indexed citations
13.
Järver, Peter, et al.. (2007). Co-transduction of Sleeping Beauty Transposase and Donor Plasmid via a Cell-penetrating Peptide: A simple one step Method. International Journal of Peptide Research and Therapeutics. 14(1). 58–63. 9 indexed citations
14.
Järver, Peter, Kent Langel, Samir EL Andaloussi, & Ülo Langel. (2007). Applications of cell-penetrating peptides in regulation of gene expression. Biochemical Society Transactions. 35(4). 770–774. 38 indexed citations
15.
Andaloussi, Samir EL, Peter Järver, Henrik J. Johansson, & Ülo Langel. (2007). Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study. Biochemical Journal. 407(2). 285–292. 204 indexed citations
16.
Andaloussi, Samir EL, Henrik J. Johansson, A. Magnusdottir, et al.. (2005). TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein. Journal of Controlled Release. 110(1). 189–201. 59 indexed citations
17.
Andaloussi, Samir EL, Peter Järver, Andres Valkna, et al.. (2005). Evaluation of transportan 10 in PEI mediated plasmid delivery assay. Journal of Controlled Release. 103(2). 511–523. 63 indexed citations
18.
Järver, Peter, et al.. (2004). The use of cell-penetrating peptides as a tool for gene regulation. Drug Discovery Today. 9(9). 395–402. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026